MECC Coronavirus (COVID 19) Weekly Report

MECC Coronavirus (COVID 19) Weekly Report .png

SYRIA: COVID-19

Humanitarian Update No. 48

Reporting period: from 15 to 21 February 2021

Coronavirus cases: 15143 Active cases: 5003 Recovered: 9144 Deaths: 996   [1]

 

Highlights

Coronavirus - Syria.PNG
  • In GoS-controlled areas of the country,(as of 20 Feb), the Syrian Ministry of Health (MoH) reported 15143 Laboratory-confirmed cases, 996 fatalities, and 9144 Recoveries.

  • 15143 laboratory-confirmed cases have been reported by the Syrian MoH : 2961 in Damascus; 2250 in Aleppo; 2248 in Homs; 2222 in Lattakia; 1465 in Rural Damascus; 1147 in Tartous; 941 in Dar’a; 843 in Sweida; 708 in Hama; 257 in Quneitra; 59 in Deir-Ez-Zor; 35 in Al-Hasakeh and 7 in Ar-Raqqa.

  • In NES, as of 16 February, there have been 8,537confirmed cases of COVID-19. Of these, 6,022are currently recorded as active, 2,095 have recovered, and 419 deaths (264 among lab-confirmed cases).

  • In NWS, as of16 February, a total of 21,072confirmed cases of COVID-19 have been reported. The total number of COVID-19 associated deaths is 407. Of confirmed cases, 2,210 living in camps (10.5 per cent of the total). Out of the total number of cases,17,000 have recovered, and 3,416are active cases. Just over eight per cent (1,548) of the total number of cases have  been health  care  workers.

    

Preparedness and response

  • During the reporting period, more than 8,985 suspected COVID-19 cases were  investigated  properly  within  24  hours;  in  addition,  WHO  supported  the  transport  of  4,146  specimens  of  suspected cases to the central laboratories.

  • WHO supported workshops on COVID-19 surveillance, with 175 health workers out of the 400 planned trained to date on COVID-19 investigation and response for cases reported at schools.

  • WHO  supported  three  training  workshops  on  enhancing  PoE  capacity,  focused  on enhancing PoE  preparedness  and  response  capacity,specifically  IPC  measures  and  risk  communication.  A  total  of  75 people  from  14  governorates  participated.

  • In the reporting period, WHO supported molecular  biology,  SARS-CoV-2  diagnosis  training  for  laboratory  technicians  in  Aleppo,  Lattakia,  Homs  and  Rural Damascus.

  • WHO conducted a needs assessment at isolation hospitals in Tartous, focusingon IPC/PPE measures. Training in IPC and the use of PPE also continued. In the reporting period, WHO supported training for 125 health care workers in Hama, Rural Damascus, Lattakia, Quneitra and Dar’a on IPC/PPE.

  • In NWS, Infection Prevention and Control (IPC) specialized training was delivered to 8 COVID-19 Community treatment centres (CCTC) covering 312 medical and non-medical staff. Currently, WHO is looking to extending its support to the IPC project for a further six months.

  • In  the  reporting  period,  WHO  supported  training  for  125  health workers including immediate life support and ventilator management in Damascus and Homsand60 health workers on the newly established emergency isolation centre in Damascus on case management.

  • WHO provided several isolation hospitals with lifesaving medicines, anaesthesia medicines and medical equipment, including two portable ventilators.

  • In NWS, During this reporting period, a total of 3,167were admitted to CCTC. WHO is currently looking to extend its support to Al-Sham Dana COVID-19 designated hospital to the 25 July.

  • The Logistics Cluster facilitated the transportation of 3MT of Health Sector cargo by air from Damascus to Qamishli. This is in addition to a UNHAS service for air passengers between Damascus and Qamishli. During the reporting period, the UNHAS service expanded to include twice-weekly flights to Aleppo.

  • During the reporting period, more than 8,985 suspected COVID-19 cases were  investigated  properly  within  24  hours;  in  addition,  WHO  supported  the  transport  of  4,146  specimens  of  suspected cases to the central laboratories.

  • WHO supported workshops on COVID-19 surveillance, with 175 health workers out of the 400 planned trained to date on COVID-19 investigation and response for cases reported at schools.

Vaccines

  • Syria is one of the 92 countries eligible for Advanced Market Distribution (AMD) of COVID-19 vaccines under the COVAX facility, a partnership between the World Health Organization (WHO), the Coalition for Epidemic Preparedness Innovations (CEPI), and the Global Alliance for Vaccines and Immunization (GAVI).[2]

  • In  coordination  with  UNICEF,  WHO continues  its  engagement  with  the  MoH  concerning  technical  assistance  for the documentation needed for  the COVID-19 Vaccine application process under COVID-19 Vaccines Global Access Facility (COVAX).

  • Part A of the application was signed by the MoH and submitted to GAVI on 15 December 2020. Part B (legal) of the  COVAX  application  is still  under  consideration.

  • As  of  January,  all  the  necessary  coordination  committees  (National Coordination  Committee –NCC;COVID-19  Technical  Advisory  Group –cTAG; and the Inter-Agency  Coordination Committee-ICC)  and  adjusted  TORs  have  been  approved,  with  ten  technical  sub-committees  formed  with  WHO  and UNICEF representation.

  • Ongoing essential work includes WHO support for a National Readiness Assessment tool, endorsed by the MoH on 20 January.  This includes a set of 50 key operational activities.

  • Additionally, work is ongoing to support other planning necessary for vaccine rollout, including developing IPC and waste management  protocols,  national  cold  chain  inventory,  and  planning  to  target  hard-to-reach  areas,  including  camps  and settlements.

  • At  present,  the national  authorities  collect  and  consolidate  population  data  (including  from  the  Ministry  of Planning,  Central  Statistics  Office,  Syndicate  of  Doctors  and  Health  Workers  at  national  and  governate  levels).

  • Per the COVAX Interim Distribution Forecast, Syria could receive up to 1.02 M vaccine doses in Q 1and Q 2.

  • In NES, As per the prioritization criteria established under the Syria National Deployment and Vaccination Plan (NDVP). WHO will lead the initial vaccination rollout in NES, building on the network of public health facilities and mobile teams which have been utilized to support Expanded Programme on Immunization (EPI) 

  • In NWS, planning is underway for COVID-19 vaccinations, with preliminary discussions focused on vaccinating some 20 percent of the northwest Syria population through COVAX. The WHO Gaziantep office, together with UNICEF, has submitted COVAX applications relying, for the implementation, on the currently existing immunization programme modalities in northwest Syria.[3]

 

Lebanon: COVID-19

Humanitarian Update No. 45

Reporting period: from 16 to 22 February 2021

Coronavirus cases: 355,073 Deaths: 4,340 Recovered: 268,071

  

Highlights

Recent corona-related figures from the WHO.

Recent corona-related figures from the WHO.

Dr. Hamad Hassan: Since there is no other alternative, the vaccine is the only solution.

Dr. Hamad Hassan: Since there is no other alternative, the vaccine is the only solution.

  • During this reporting period, the average number of cases per day dropped to 2,366.

  • The Minister of Industry in the caretaker government, Imad Hoballah, the Russian ambassador, Alexander Rudakov, visited the factory of "Arawan" for pharmaceutical industries in the town of Jadra on the Chouf coast, in Iqlim al-Kharroub region, to discuss the possibility of producing the Russian vaccine in Lebanon.

  • The Ministry of Public Health began supervising the implementation of the national vaccination campaign in the various centers that have been identified through its medical teams deployed in all Lebanese regions, based on the national plan for vaccination prepared by the Ministry and approved by the Lebanese government.

  • According to the Minister of Public Health, Dr. Hamad Hassan, 650, 000 Lebanese have already registered to attain the vaccine.

  • The Minister of Public Health announced that Lebanon needs two million additional doses of the anti-Coronavirus vaccine in addition to those that were secured under previous agreements (six million doses: two million and one hundred thousand from Pfizer, two million and 750 thousand via Kovacs, one and a half million from AstraZeneca still in operation).

  • The Minister of Public Health discussed with the Russian ambassador the issue of bringing the Russian vaccine "Sputnik", in light of the decision of the Russian Investment Fund to complete cooperation in this field directly through the Ministry of Public Health, while encouraging the participation of private and sectoral initiatives from unions and institutions.

  • The Minister of Public Health launched two vaccination campaigns at Tibnin Governmental Hospital and Bint Jbeil Governmental Hospital, which had received from the Ministry of Public Health 180 doses. They will be given to the medical and nursing staff and some names registered on the online platform according to the order of registration and attendance.

  • The General Directorate of General Security reported several gatherings/ demonstrations due to the worsening socioeconomic conditions and the removal of prosecutor Fady Sawan.

[1]  Microsoft power MOH,20 Feb 2021

[2] WHO.int

[3] SYRIAN ARAB REPUBLICCOVID-19 Response Update No.15 As of 16 February2021

Communication and Public Relations Department

Previous
Previous

Families of the victims of the Beirut blast

Next
Next

Interview: The Middle East Church Must Resemble Salt, not Rabbits